1 FTSE 100 stock I wouldn’t miss buying in November

This FTSE 100 stock has seen a decline in share price in recent months. But that might be about to change as we head for better times. 

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

The pandemic seems to be on its last legs and the economy is all but fully functional now. Because of this, financial results for FTSE 100 companies have been on the mend. But traces of the pandemic’s impact are still visible for some of them and can be seen in their share prices. One such company caught my attention recently. I think it could make a great buy for my portfolio in November, before its price starts rising again.

Impacted by coronavirus

I am talking about the healthcare company Smith & Nephew (LSE: SN). I think healthcare stocks are good to have in my investment portfolio during economic slowdowns. Demand for such companies’ products and services is relatively resilient at such times. Even then, Smith & Nephew took a bit of a hit last year because of the unique nature of the pandemic slowdown. 

To reduce the risk of spreading Covid-19, elective surgeries were postponed, including knee and hip replacements. Smith & Nephew supplies the parts for such replacements and this segment is also its biggest revenue generator, accounting for over 40% of the total. In its trading statement for the third quarter, released yesterday, its revenue for the segment is down by 0.7% from the same quarter last year, even though overall revenues are up by 5.5%. 

Smith & Nephew sees a share price decline 

Its outlook has been slightly impacted as well. Smith & Nephew now says that it will “deliver at the low end of full year guidance”. Its share price has likely been affected by its somewhat weak performance too. Over the past year, it has declined by 13%. There is a possibility that it may decline even more, considering that the price-to-earnings (P/E) ratio is more than 35 times, as per my estimates. This is quite pricey, considering the average FTSE 100 stock is valued at 20 times its earnings. 

Why I like the FTSE 100 stock

So why do I say that I would not miss buying it in November, exactly? That is because one year from now, I think the stock will look far more attractive than it appears to be now. Its performance could improve as life is now almost back to normal. And this is likely to be reflected in its earnings too. At current price levels, increased earnings would mean a lower P/E ratio, potentially making it more affordable. 

There is no guarantee that its P/E will ever come down to the FTSE 100 average level. It is a defensive stock that has performed well over time. Based on the information I have, I see no reason to believe it would be any different in the future either. Here, I am reminded of a valuable lesson I learned from buying another healthcare stock, AstraZeneca, some time ago. 

AstraZeneca has always been highly priced compared to its earnings. At present, its P/E is 44 times, and that is not even the highest it has seen. Yet, it has been a good stock for me to hold, providing largely steady capital gains over time. I think a similar story could play out for Smith & Nephew. I will buy it this month. 


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh owns shares of AstraZeneca. The Motley Fool UK has recommended Smith & Nephew. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Is the FTSE 100 becoming increasingly disconnected from the UK economy?

The FTSE 100's broken through the 9,000 barrier for the first time, yet the British economy's shrinking. Should investors be…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

I’ve just invested £12.06 in this FTSE 250 stock

Why has a FTSE 250 housebuilder that Stephen Wright's been watching for some time suddenly jumped to the top of…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Why I think the FTSE 250 could outperform the FTSE 100 this decade

Our writer takes a lesson from history and outlines why he thinks the FTSE 250 could beat the FTSE 100…

Read more »

Female Tesco employee holding produce crate
Investing Articles

Is there any reason NOT to open a Stocks and Shares ISA?

A Stocks and Shares ISA is one of the best ways to grow wealth with tax benefits. But there are…

Read more »

Mother At Home Getting Son Wearing Uniform Ready For First Day Of School
Investing Articles

Want an early retirement for your child? Here’s how a SIPP can help

None of us want our children to be worrying about the future. Dr James Fox explains how a SIPP started…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Looking for growth, dividends, or value? These 3 investment trusts could be strong options to consider

These three top investment trusts have delivered exceptional double-digit returns in recent years, as Royston Wild explains.

Read more »

View of the Birmingham skyline including the church of St Martin, the Bullring shopping centre and the outdoor market.
Investing Articles

How to create a second income from UK property without purchasing a buy-to-let

Looking to build a second income from property but don’t have the capital for a buy-to-let? Check out REITs, says…

Read more »

High flying easyJet women bring daughters to work to inspire next generation of women in STEM
Investing Articles

In 12 months, a £10,000 investment in easyJet shares could become…

easyJet shares have plunged in value following a profit warning on Thursday (17 July). Can the FTSE 100 travel share…

Read more »